Home Search
Stem cell gene therapy - search results
If you're not happy with the results, please do another search
Japan: A case study of national “readiness” for regenerative medicine
This article focuses on Japan, as a country with a strong and distinctive strategy for delivering RM, and outlines efforts to build regenerative readiness.
The future of regenerative cell therapeutics
Tobias Deuse, Cardiac Surgeon and Scientist at University of California San Francisco, reveals to us the future of regenerative cell therapeutics.
What are the challenges surrounding gene therapy today?
Dr Jen Vanderhoven, Director, National Horizons Centre, Teesside University, sheds some light on how the gene therapy field can progress in the face of funding challenges and skills shortages.
Scientists successfully use gene therapy to restore eyesight
Scientists in France have partially restored the eyesight of a blind man, using gene therapy - he is now able to identify blurry shapes.
Today’s challenge of treating genetic diseases
Professor Olivier Braissant highlights here, how the challenges of treating genetic diseases can be exemplified by research on creatine transporter deficiency.
From insulin to immunotherapy: A century of discovery
Dr Faye Riley, Senior Research Communications Officer at Diabetes UK, highlights how immunotherapy is raising hopes for the next big breakthrough in type 1 diabetes.
FLASH Radiotherapy: An (r)evolution in cancer treatment
Here, Kristoffer Petersson, MRC Investigator and Group Leader of FLASH Radiation, enlightens us to the benefits of this promising new radiotherapy technique.
The mind-body concept: From philosophy to clinical therapy
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, explains the mind-body concept, from a philosophical question to clinical therapy.
Rethinking Type 1 diabetes with a radically new immunotherapy approach
Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces Imotopes™, the innovative new immunotherapy approach causing scientists to rethink Type 1 diabetes and its treatment.
Pyroptotic cell death: Controlled self-destruct that causes inflammation and disease
Associate Professor Petr Broz discusses pyroptotic cell death, the controlled cellular explosion that can harm your health.
Could placenta cells save patients with severe COVID-19?
Israeli therapeutics firm, Pluristem, have recently pioneered a breakthrough treatment which administers a unique placenta-based cell therapy to COVID-19 patients who have been identified as high-risk mortality cases.
Umbilical cord stem cells have the potential to treat COVID-19
Studies suggest that the use of mesenchymal stem cells collected from umbilical cord blood and tissue are a safe and effective way to alleviate symptoms of coronavirus and promote fast recovery.
Elucidating the pathogenesis of paediatric cancers
Prof Nicolo Riggi and Prof Ivan Stamenkovic from the University of Lausanne share their thoughts on the pathogenesis of paediatric cancers.
Could hormone replacement therapy boost your immune system?
Dr Deborah Lee, Dr Fox Online Pharmacy, discusses whether hormone replacement therapy could boost your immune system in the face of the COVID-19 pandemic.
Exciting new regenerative treatments take centre stage for knees
Professor Adrian Wilson, MBBS, BSc (Hons), FRCS, FRCS Tr & Orth Specialist Knee Surgeon (Professor), tells us what we need to know about exciting new regenerative treatments that take centre stage for knees in the world of orthobiologics.
Repurposing FDA-approved medicines and gene therapy to combat diabetic retinopathy
Lalit Singh Pukhrambam, PhD, and Ahmed S Ibrahim, PhD from Wayne State University School of Medicine in the U.S. focus here on the importance of combating diabetic retinopathy.
Scientists discover way to protect hair from chemotherapy
Scientists have determined a new way to protect the hair follicle from chemotherapy in an effort to prevent hair loss as a result of cancer treatments.
Developments in red blood cells at the Mount of Truth
The European Red Cell Society’s met the partners of the EU intellectual training network RELEVANCE at Mount of Truth in Ascona, Switzerland to discuss the latest progress.
Nano DDS technology contributes to next-generation cancer immunotherapy
Dr Takashi Nakamura from Hokkaido University challenges the potential of nano-tech based drug delivery system (Nano DDS) in the development of next-generation cancer immunotherapy.
New treatments for neurodegenerative diseases
Professor Dame Pamela Shaw explains how the National Institute for Health Research (NIHR) supports experimental medicine and translational research in neurodegenerative diseases.
